Objective: As the frequency of skin cancers continues to increase, the aim of this study was to determine the incidence of precancerous and cancerous skin lesions diagnosed and treated during 2016 at the dermatology outpatient clinics of 3 private hospitals in 3 cities in Turkey.
INTRODUCTION
Although benign, skin lesions with a >10% chance of becoming cancerous over time are referred to precancerous lesions. [1] Precancerous skin lesions include actinic keratosis (AK), Bowen's disease, Queyrat erythroplasia, Bowenoid papulosis, and parapsoriasis en plaques. The frequency of skin cancers is increasing worldwide. Cancerous skin lesions include basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) (the 2 most common), malignant melanoma (MM), mycosis fungoides (MF), Kaposi's sarcoma, and other rare skin appendageal tumors. The aim of the present study was to determine the incidence of precancerous and cancerous skin lesions diagnosed and treated in 2016 at the dermatology outpatient clinics of 3 private secondary healthcare centers in 3 cities in Turkey.
MATERIAL AND METHODS
This retrospective multicenter study examined the records of all patients who presented at the dermatology outpatient clinic at Ankara Medicalpark Hospital, Ankara, Turkey; Kocaeli VM Medicalpark Hospital, Kocaeli, Turkey; and Istanbul Fatih Medicalpark Hospital, Istanbul, Turkey (all secondary private healthcare institutions) during 2016. The number of patients, the male to female ratio, and mean age were calculated. The International Classification of Diseases codes were used to identify patients clinically and/or histopathologically diagnosed with precancerous and cancerous skin lesions, and then the patients' demographic and clinical details were obtained from their medical records. The study protocol was approved by the Bahçeşehir University Ethics Committee (BAU KAEK 2017-04/01), and the study was conducted in accordance with the Declaration of Helsinki.
Descriptive statistics are shown as mean±SD, median, range, frequency, and percentage. The normality of the distribution of the data was determined via the KolmogorovSmirnov test. The Mann-Whitney U test was used to analyze independent quantitative data. Independent qualitative data were analyzed using a chi-square test and Fischer's test was used when the chi-square test conditions were not met. Data analysis was performed using IBM SPSS Statistics for Windows, Version 22.0 (IBM Corp., Armonk, NY, USA). The level of statistical significance was set at p<0.05.
RESULTS
A total of 21,085 patients presented at the 3 dermatology outpatient clinics in 2016. Patient characteristics are summarized in Table 1 . Among the patients, there were 81 cases of precancerous and cancerous lesions, for an annual incidence of 0.38%. The annual incidence of precancerous lesions (n=58) was 0.27%, versus 0.11% (n=23) for cancerous lesions ( Table 2 ). Precancerous lesions included AK, Bowen's disease, Bowenoid papulosis, and parapsoriasis, and cancerous lesions diagnosed included BCC, SCC, MM, MF, Kaposi's sarcoma, and skin metastasis of distant organ cancers (Table 3) . Patient age and gender, hospital distribution, the comorbid disease rate, and lesion duration did not differ significantly between the patients with precancerous and cancerous lesions (p>0.05). Head and neck localization, and the incidence of ≥2 lesions were significantly higher (p<0.05) in the patients with precancerous lesions than in those with cancerous lesions. Significantly more patients with cancerous lesions underwent biopsy, surgical treatment, and other treatments (radiotherapy, chemotherapy, and phototherapy), compared with those with precancerous lesions (p<0.05). The cryosurgery/electrosurgery rate was significantly higher in the patients with precancerous lesions than in those with cancerous lesions (p<0.05). The rate of topical treatment (topical corticosteroids, 5-fluorouracil 5% cream and diclofenac sodium 3% cream) did not differ significantly (p>0.05) between the patients with precancerous and cancerous lesions (Table 4) .
DISCUSSION
The prevalence of precancerous and cancerous skin lesions is increasing worldwide. [2] Turkey is bound by 3 seas and is located between the temperate and subtropical climate zones. As such, precancerous and cancerous skin lesions, especially due to the effects of sunlight, are common in Turkey. The incidence of cancer among all pathology specimens obtained in Mersin, Turkey between 1989 and 1999 was 7.71%, of which the most common was skin cancer (22.38% of all cancer cases and 1.73% of all pathology specimens). [3] A study on the 1-year incidence of cancer in Hatay, Turkey reported that the most common cancer was skin cancer (27.7%). [4] Two other retrospective studies conducted in Turkey included all dermatology patients aged >65 years, reporting that the frequency of precancerous and cancerous skin lesions was 5.2% to 9.4%, [5, 6] and that it increased with patient age (4.6%-12.5%). [5] Additionally, it was reported that between 1999 and 2003 the frequency of precancerous and cancerous skin lesions in Turkey increased almost 1.5-fold (4.0%-6.4%). [5] One Turkish study observed that skin tumors are the most common skin finding in the population aged >65 years in Ankara, with a rate of 81.5%, including benign, precancerous, and cancerous tumors, and that among the precancerous skin tumors, 19% were AK. [7] A retrospective study of geriatric patients who presented at a dermatology outpatient clinic in Yozgat, Turkey reported that the frequency of AK was 3.8%. [6] A Korean study found that the prevalence of precancerous skin lesions was 0.16% (71.2% of all cases were AK). [2] Another Korean study observed that the annual incidence of precancerous skin lesions was 1.82%. [8] The frequency of AK in the northern hemisphere is 11% to 25% in the population aged >40 years. [9] In a British study, it was reported that the incidence of AK was 3% to 6% in males aged 40-49 years and 20% in males aged >60 years. [9] Dutch researchers reported that the prevalence of AK in males aged >45 years was 49%, while it was 28% in females similarly aged. [10] In the present study, the mean age of all of the patients was 35.3 years, whereas the mean age of the patients with precancerous skin lesions was 65.4 years. In addition, among the present study's patient population, the annual incidence of presentation due to AK was 0.25%, versus 0.28% due to precancerous skin lesions.
Korean research found an incidence of cancerous skin lesions of 0.3%. [2] The retrospective study of geriatric patients who presented at a dermatology outpatient clinic in Yozgat reported that the incidence of cancerous skin lesions was 1.36%. [6] A retrospective study from China that included 19 years of data reported that a biopsy-based diagnosis of precancerous and cancerous lesions was prevalent among lesions of the head and neck, trunk, and extremities, and that mean age at diagnosis was 62.27 years. [11] In that Chinese study, BCC was the most commonly diagnosed cancer, followed by AK, SCC in situ, SCC, MF, and MM. A Turkish study on AK biopsy specimens observed that 13% of AK lesions were harboring SCC and 19% were harboring BCC. [12] Turkish research on the frequency of skin findings in individuals aged >65 years reported that 1% of cancers were BCC. [7] The study of geriatric dermatology outpatient patients in Yozgat found that the frequency of BCC was 0.81%, versus 0.27% for SCC. [6] The annual incidence of SCC was reported to be 0.03% in the general French population. [9] In the study of pathology specimens in Mersin, it was determined that among all skin cancers, the most common was BCC (74.44% of skin cancers and 1.29% of all specimens), followed by SCC (19.16% of skin cancers and 0.33% of all pathologic specimens), and MM (4.91% of skin cancers and 0.08% of all pathology specimens). [3] The annual incidence of SCC in the present study was 0.03%. Interestingly, the annual incidence of BCC, SCC, and MF in the present study was similar (Table 3 ).
The retrospective design and the possibility that not all patients were included due to record-keeping errors are limitations of the present study. Furthermore, precancerous and cancerous lesions may have been missed in some patients who presented with complaints of other cutaneous lesions, and not recorded.
Conclusion
The present study determined the annual incidence for 2016 of precancerous and cancerous skin lesions among all patients who presented at 3 second level healthcare facility dermatology outpatient clinics. The study included patients from 2 regions of Turkey (Marmara and inner Anatolia) and we think that the findings could be used as a reference for dermatology outpatient clinics in other second level healthcare facilities. However, had the size of the study population been larger and the duration of the study been longer, we could be more certain about our generalizations.
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